Retained NK Cell Phenotype and Functionality in Non-alcoholic Fatty Liver Disease.

Natalie Stiglund, Kristina Strand, Martin Cornillet, Per Stål, Anders Thorell, Christine L Zimmer, Erik Näslund, Silja Karlgren, Henrik Nilsson, Gunnar Mellgren, Johan Fernø, Hannes Hagström, Niklas K Björkström

Journal: Frontiers in immunology 2020;10():1255

PMID: 31214196

Abstract

Non-alcoholic fatty liver disease (NAFLD), and the progressive stage non-alcoholic steatohepatitis (NASH), is the predominant cause of chronic liver disease globally. As part of the complex pathogenesis, natural killer (NK) cells have been implicated in the development of liver inflammation in experimental murine models of NASH. However, there is a lack of knowledge on how NK cells are affected in humans with this disease. Here, we explored the presence of disease-specific changes within circulating and tissue-resident NK cell populations, as well as within other major immune cell subsets, in patients with liver biopsy-confirmed NAFLD. Using 18-color-flow cytometry, substantial changes were observed in certain myeloid populations in patients as compared to controls. NK cell numbers, on the other hand, were not altered. Furthermore, only minor differences in expression of activating and inhibitory NK cell receptors were noted, with the exception of an increased expression of NKG2D on NK cells from patients with NASH. NK cell differentiation remained constant, and NK cells from these patients retain their ability to respond adequately upon stimulation. Instead, considerable alterations were observed between liver, adipose tissue, and peripheral blood NK cells, independently of disease status. Taken together, these results increase our understanding of the importance of the local microenvironment in shaping the NK cell compartment and stress the need for further studies exploring how NASH affects intrahepatic NK cells in humans.

Address: Department of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.; Hormone Laboratory, Haukeland University Hospital, Bergen, Norway.; Mohn Nutrition Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Upper GI, Karolinska University Hospital, Stockholm, Sweden.; Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.; Department of Surgery, Ersta Hospital, Stockholm, Sweden.; Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Solna, Sweden.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.